{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:29Z","timestamp":1786985609077,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["13\/IA\/1994"],"award-info":[{"award-number":["13\/IA\/1994"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAPES, Coordination for the Improvement of Higher Education Personnel \u2013 Brazil","award":["013306\/2013-08"],"award-info":[{"award-number":["013306\/2013-08"]}]},{"name":"NCI\/DTP Open Chemical Repository","award":["NSC 333856"],"award-info":[{"award-number":["NSC 333856"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.canlet.2018.09.032","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:23:34Z","timestamp":1539091414000},"page":"23-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth"],"prefix":"10.1016","volume":"440-441","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5459-7768","authenticated-orcid":false,"given":"Sri HariKrishna","family":"Vellanki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo G.B.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Jahns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Eramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-6584","authenticated-orcid":false,"given":"Ann M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.09.032_bib1","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1158\/1078-0432.CCR-09-0636","article-title":"Resistance to trastuzumab in breast cancer","volume":"15","author":"Pohlmann","year":"2009","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib2","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1158\/1078-0432.CCR-16-2191","article-title":"HER2 reactivation through acquisition of the HER2 L755S mutation as a mechanism of acquired resistance to HER2-targeted therapy in HER2(+) breast cancer","volume":"23","author":"Xu","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib3","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/onc.2012.276","article-title":"Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling","volume":"32","author":"Brennan","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.09.032_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ijc.24498","article-title":"JAM-A expression positively correlates with poor prognosis in breast cancer patients","volume":"125","author":"McSherry","year":"2009","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2018.09.032_bib5","doi-asserted-by":"crossref","first-page":"33887","DOI":"10.18632\/oncotarget.8432","article-title":"Dysregulation of junctional adhesion molecule-A via p63\/GATA-3 in head and neck squamous cell carcinoma","volume":"7","author":"Kakuki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.09.032_bib6","article-title":"Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.09.032_bib7","first-page":"921","article-title":"Analysis of the expression and localization of tight junction transmembrane proteins, claudin-1, -4, -7, occludin and JAM-A, in human cervical adenocarcinoma","volume":"31","author":"Akimoto","year":"2016","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.canlet.2018.09.032_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/carcin\/bgu230","article-title":"Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer","volume":"36","author":"Tian","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2018.09.032_bib9","doi-asserted-by":"crossref","first-page":"41275","DOI":"10.18632\/oncotarget.5753","article-title":"Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus","volume":"6","author":"Kelly","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.09.032_bib10","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/stem.2021","article-title":"Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer","volume":"33","author":"Thiagarajan","year":"2015","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2018.09.032_bib11","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1038\/s41598-017-07964-5","article-title":"JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2018.09.032_bib12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ijc.27772","article-title":"A novel role for junctional adhesion molecule-A in tumor proliferation: modulation by an anti-JAM-A monoclonal antibody","volume":"132","author":"Goetsch","year":"2013","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2018.09.032_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021242","article-title":"Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression","volume":"6","author":"Murakami","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.09.032_bib14","unstructured":"N.D.O.C. Repository, dtp.cancer.gov."},{"key":"10.1016\/j.canlet.2018.09.032_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7164\/antibiotics.33.244","article-title":"A new antibiotic, antlermicin A","volume":"33","author":"Kobinata","year":"1980","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.canlet.2018.09.032_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbrc.2007.02.136","article-title":"Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers","volume":"356","author":"Nakajima","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2018.09.032_bib17","first-page":"1229","article-title":"Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity","volume":"60","author":"Nakashima","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0960-894X(01)00094-4","article-title":"Synthesis of tetrocarcin derivatives with specific inhibitory activity towards Bcl-2 functions","volume":"11","author":"Kaneko","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.canlet.2018.09.032_bib19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7164\/antibiotics.35.1033","article-title":"Tetrocarcins, new antitumor antibiotics. 3. Antitumor activity of tetrocarcin A","volume":"35","author":"Morimoto","year":"1982","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.canlet.2018.09.032_bib20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-05-1182","article-title":"Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells","volume":"66","author":"Konecny","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-4598-13-157","article-title":"PP2A inhibition overcomes acquired resistance to HER2 targeted therapy","volume":"13","author":"McDermott","year":"2014","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2018.09.032_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043752","article-title":"CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal Transition","volume":"7","author":"Imbert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2018.09.032_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-9966-30-45","article-title":"An imbalance in progenitor cell populations reflects tumour progression in breast cancer primary culture models","volume":"30","author":"Donatello","year":"2011","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2018.09.032_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/1758834017746040","article-title":"Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers","volume":"10","author":"Milewska","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.canlet.2018.09.032_bib26","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1158\/1078-0432.CCR-11-0075","article-title":"Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis","volume":"17","author":"Unterkircher","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature04323","article-title":"Potentiation of neuroblastoma metastasis by loss of caspase-8","volume":"439","author":"Stupack","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.09.032_bib28","unstructured":"www.oncomine.com, August, 2017, Thermo Fisher Scientific, Ann Arbor, MI."},{"key":"10.1016\/j.canlet.2018.09.032_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4757-3147-7_4","article-title":"The molecular and cellular biology of HER2\/neu gene amplification\/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer","volume":"103","author":"Pegram","year":"2000","journal-title":"Cancer Treat Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib30","first-page":"1397","article-title":"Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1","volume":"29","author":"Yde","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2018.09.032_bib31","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/blood-2003-04-1114","article-title":"Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex","volume":"102","author":"Naik","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2018.09.032_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1242\/jcs.02771","article-title":"Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific","volume":"119","author":"Naik","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2018.09.032_bib33","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1073\/pnas.1523693113","article-title":"Pten loss promotes MAPK pathway dependency in HER2\/neu breast carcinomas","volume":"113","author":"Ebbesen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2018.09.032_bib34","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.febslet.2005.06.047","article-title":"HER2 signaling downregulation by trastuzumab and suppression of the PI3K\/Akt pathway: an unexpected effect on TRAIL-induced apoptosis","volume":"579","author":"Dubska","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2018.09.032_bib35","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cellsig.2009.02.006","article-title":"ERK1\/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos","volume":"21","author":"Gilley","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2018.09.032_bib36","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1","volume":"280","author":"Monje","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.09.032_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.onc.1209759","article-title":"Transcription factors control invasion: AP-1 the first among equals","volume":"26","author":"Ozanne","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.09.032_bib38","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/carcin\/bgs223","article-title":"Interplay between AP-1 and estrogen receptor alpha in regulating gene expression and proliferation networks in breast cancer cells","volume":"33","author":"Dahlman-Wright","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2018.09.032_bib39","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bbamcr.2006.11.011","article-title":"Regulation of gene transcription by mitogen-activated protein kinase signaling pathways","volume":"1773","author":"Whitmarsh","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2018.09.032_bib40","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1038\/sj.onc.1208905","article-title":"cFos is critical for MCF-7 breast cancer cell growth","volume":"24","author":"Lu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.09.032_bib41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbamcr.2006.06.006","article-title":"Interplay between PI3K\/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis","volume":"1763","author":"Lee","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2018.09.032_bib42","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1038\/onc.2008.315","article-title":"The p53 family and programmed cell death","volume":"27","author":"Pietsch","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.09.032_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: outer membrane permeabilization and beyond","volume":"11","author":"Tait","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2018.09.032_bib44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm735","article-title":"Smac agonists sensitize for Apo2L\/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo","volume":"8","author":"Fulda","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2018.09.032_bib45","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2018.09.032_bib46","first-page":"1213","article-title":"Protein kinase A and AP-1 (c-Fos\/JunD) are induced during apoptosis of mouse mammary epithelial cells","volume":"9","author":"Marti","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.09.032_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/nnm.12.22","article-title":"Cancer stem cells and drug resistance: the potential of nanomedicine","volume":"7","author":"Vinogradov","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2018.09.032_bib48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.09.032_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10549-006-9186-z","article-title":"Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines","volume":"99","author":"Wasielewski","year":"2006","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2018.09.032_bib50","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/sj.bjc.6605335","article-title":"Mutant p53 mediates survival of breast cancer cells","volume":"101","author":"Lim","year":"2009","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2018.09.032_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1014594825502","article-title":"Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant","volume":"19","author":"dit Faute","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2018.09.032_bib52","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1158\/0008-5472.CAN-06-3731","article-title":"Degradation of HER2 by Cbl-based chimeric ubiquitin ligases","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.09.032_bib53","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1021\/acsnano.5b05138","article-title":"Enhanced human epidermal growth factor receptor 2 degradation in breast cancer cells by lysosome-targeting gold nanoconstructs","volume":"9","author":"Lee","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2018.09.032_bib54","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/bjc.2011.132","article-title":"Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer","volume":"104","author":"Vincent","year":"2011","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2018.09.032_bib55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3346\/jkms.2009.24.4.605","article-title":"Overexpression of X-linked inhibitor of apoptosis protein (XIAP) is an independent unfavorable prognostic factor in childhood de novo acute myeloid leukemia","volume":"24","author":"Sung","year":"2009","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.canlet.2018.09.032_bib56","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.humpath.2004.03.011","article-title":"XIAP expression is an independent prognostic marker in clear-cell renal carcinomas","volume":"35","author":"Ramp","year":"2004","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2018.09.032_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2407-9-125","article-title":"Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma","volume":"9","author":"Augello","year":"2009","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2018.09.032_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1615\/CritRevOncog.2016017032","article-title":"The IAP protein family, SMAC mimetics and cancer treatment","volume":"21","author":"Philchenkov","year":"2016","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.canlet.2018.09.032_bib59","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1021\/jm500176w","article-title":"Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies","volume":"57","author":"Condon","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2018.09.032_bib60","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.7150\/ijms.21428","article-title":"Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer","volume":"14","author":"Lin","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.canlet.2018.09.032_bib61","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/carcin\/bgr028","article-title":"Breast cancer stem cells: treatment resistance and therapeutic opportunities","volume":"32","author":"Al-Ejeh","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2018.09.032_bib62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.celrep.2013.11.043","article-title":"High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor","volume":"6","author":"Lathia","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2018.09.032_bib63","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.3390\/ijms13089959","article-title":"Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis","volume":"13","author":"Lokman","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2018.09.032_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1538\/expanim.14-0059","article-title":"Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs","volume":"64","author":"Kue","year":"2015","journal-title":"Exp. Anim."},{"key":"10.1016\/j.canlet.2018.09.032_bib65","first-page":"340","article-title":"Targeting cancer stem cells: a new therapy to cure cancer patients","volume":"2","author":"Hu","year":"2012","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.canlet.2018.09.032_bib66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12015-008-9034-0","article-title":"Stemming cancer: functional genomics of cancer stem cells in solid tumors","volume":"4","author":"Regenbrecht","year":"2008","journal-title":"Stem Cell Rev."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:41:23Z","timestamp":1759592483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518306098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":66,"alternative-id":["S0304383518306098"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.09.032","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}